New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
Sex, Gender, or Both in Research Studies
Writing in JAMA, Dr. Cara Tannenbaum, from the University of Montreal and the Canadian Institutes of Health Research, and Dr. Janine Austin Clayton, from the U.S. NIH, note that until recently, most human health research has favored men, despite the fact that women comprise half the population. As a result, they and their colleagues set up the Sex and Gender Equity in Research (SAGER) guidelines that call for new reporting standards for stratifying research data by sex, gender, or both. Women metabolize certain drugs differently than men do, the scientists say, and that by not studying women or by reporting only combined results, we could be missing information critical for women's health.